1674PSafety of belotecan as second-line treatment for...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

1674PSafety of belotecan as second-line treatment for recurrent small cell lung cancer: A phase IIb randomized multicenter study

Kang, J H, Kim, H T, Lee, K H, Kim, D-W, Kim, S-W, Kim, H R, Kim, J-H, Choi, J H, An, H J, Kim, J-S, Jang, J S, Kim, B-S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy298.010
Date:
October, 2018
File:
PDF, 91 KB
2018
Conversion to is in progress
Conversion to is failed